Search
for
Sort by
Research 30 of 1000+
- Analysis of Sonic Hedgehog signalling pathway gene expression in Basal Cell Carcinoma and in GLII induced systems
- Basal cell carcinoma — molecular biology and potential new therapies
- Utility of GLI1 RNA Chromogenic in Situ Hybridization in Distinguishing Basal Cell Carcinoma From Histopathologic Mimics
- Basal Cell Carcinoma, Hedgehog Signaling, and Targeted Therapeutics: The Long and Winding Road
- Coexistence of a Basal Cell Carcinoma and Leiomyosarcoma
- Targeting of Smoothened for therapeutic gain
- Cutaneous adverse effects of targeted therapies
- 642 Uncovering the role of UV exposure history and genetics in determining skin sun damage
- 646 SOX4 is essential for melanoma tumorigenesis
- Malignant epithelial tumors: Part II. Therapy and prevention
- Oncogenes and morphogens: intricacies of targeted therapy in cutaneous basal cell carcinoma
- Scalp basal cell carcinoma: A different entity?
- Evaluation of the Tolerability of Hedgehog Pathway Inhibitors in the Treatment of Advanced Basal Cell Carcinoma: A Narrative Review of Treatment Strategies
- Experience with sonidegib in patients with advanced basal cell carcinoma: case reports
- YAP and TAZ are essential for basal and squamous cell carcinoma initiation
- Histopathological Characteristics may not be Useful in the Differential Diagnosis Between Basal Cell Carcinoma and Benign Tumors of Cutaneous Appandages Originating from Hair Follicle
- Skin Deep and Deeper: Multiple Pathways in Basal Cell Carcinogenesis
- 130 Expression of nidogen1 in basal cell carcinoma
- Management of Cutaneous and Extracutaneous Side Effects of Smoothened Inhibitor Therapy for Advanced Basal Cell Carcinoma
- Giant Morpheaform Basal Cell Carcinoma Mimicking Scarring Alopecia: Exception Prone to Neglect
- Metastatic Embryonal Cell Carcinoma with High Testosterone and Absence of Secondary Sexual Characteristics
- Distinct transcriptomic landscapes of cutaneous basal cell carcinomas and squamous cell carcinomas
- Experiences with Smo antagonist vismodegib for the treatment of locally advanced basal cell carcinoma
- Characterization and Management of Hedgehog Pathway Inhibitor-Related Adverse Events in Patients With Advanced Basal Cell Carcinoma
- A slow-cycling LGR5 tumour population mediates basal cell carcinoma relapse after therapy
- Targeting Superficial or Nodular Basal Cell Carcinoma with Topically Formulated Small Molecule Inhibitor of Smoothened
- Coexistence of a Basal Cell Carcinoma and Leiomyosarcoma: An Unusual Collision Tumor
- Ornithine decarboxylase is a target for chemoprevention of basal and squamous cell carcinomas in Ptch1+/– mice
- Ornithine decarboxylase is a target for chemoprevention of basal and squamous cell carcinomas in Ptch1+/– mice
- Notch signaling is significantly suppressed in basal cell carcinomas and activation induces basal cell carcinoma cell apoptosis